Suppr超能文献

嘌呤能信号在炎症细胞中的作用:P2 受体表达、功能效应及对炎症反应的调节。

Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses.

机构信息

Upper Airways Research Laboratory, Department of Otorhinolaryngology, Ghent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium.

出版信息

Purinergic Signal. 2013 Sep;9(3):285-306. doi: 10.1007/s11302-013-9357-4. Epub 2013 Feb 13.

Abstract

Extracellular ATP and related nucleotides promote a wide range of pathophysiological responses via activation of cell surface purinergic P2 receptors. Almost every cell type expresses P2 receptors and/or exhibit regulated release of ATP. In this review, we focus on the purinergic receptor distribution in inflammatory cells and their implication in diverse immune responses by providing an overview of the current knowledge in the literature related to purinergic signaling in neutrophils, macrophages, dendritic cells, lymphocytes, eosinophils, and mast cells. The pathophysiological role of purinergic signaling in these cells include among others calcium mobilization, actin polymerization, chemotaxis, release of mediators, cell maturation, cytotoxicity, and cell death. We finally discuss the therapeutic potential of P2 receptor subtype selective drugs in inflammatory conditions.

摘要

细胞外 ATP 及其相关核苷酸通过激活细胞表面嘌呤能 P2 受体促进广泛的病理生理反应。几乎每种细胞类型都表达 P2 受体,并且/或者表现出 ATP 的调节释放。在这篇综述中,我们通过概述与中性粒细胞、巨噬细胞、树突状细胞、淋巴细胞、嗜酸性粒细胞和肥大细胞中的嘌呤能信号相关的文献中的现有知识,重点介绍炎症细胞中的嘌呤能受体分布及其在各种免疫反应中的意义。嘌呤能信号在这些细胞中的病理生理作用包括钙动员、肌动蛋白聚合、趋化性、介质释放、细胞成熟、细胞毒性和细胞死亡。我们最后讨论了 P2 受体亚型选择性药物在炎症情况下的治疗潜力。

相似文献

1
Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses.
Purinergic Signal. 2013 Sep;9(3):285-306. doi: 10.1007/s11302-013-9357-4. Epub 2013 Feb 13.
3
Purinergic Receptors in Thrombosis and Inflammation.
Arterioscler Thromb Vasc Biol. 2015 Nov;35(11):2307-15. doi: 10.1161/ATVBAHA.115.303395. Epub 2015 Sep 10.
4
Purinergic Regulation of Neutrophil Function.
Front Immunol. 2018 Mar 1;9:399. doi: 10.3389/fimmu.2018.00399. eCollection 2018.
5
Purinergic signaling in kidney disease.
Kidney Int. 2017 Feb;91(2):315-323. doi: 10.1016/j.kint.2016.08.029. Epub 2016 Oct 22.
6
Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia.
Brain Res Brain Res Rev. 2005 Apr;48(2):144-56. doi: 10.1016/j.brainresrev.2004.12.004. Epub 2005 Jan 22.
7
P2 receptors and extracellular ATP: a novel homeostatic pathway in inflammation.
Front Biosci (Schol Ed). 2011 Jun 1;3(4):1443-56. doi: 10.2741/235.
9
Control of Gut Inflammation by Modulation of Purinergic Signaling.
Front Immunol. 2020 Sep 25;11:1882. doi: 10.3389/fimmu.2020.01882. eCollection 2020.

引用本文的文献

1
Anti-β2GPI/β2GPI complex promotes thrombosis by activating the P2Y2/MAPKs pathway to increase human neutrophil peptides.
PLoS One. 2025 May 22;20(5):e0322447. doi: 10.1371/journal.pone.0322447. eCollection 2025.
2
Role of macrophage ATP metabolism disorder in SiO‑induced pulmonary fibrosis: a review.
Purinergic Signal. 2025 May 13. doi: 10.1007/s11302-025-10093-8.
3
P2 receptors signaling in the esophagus: from inflammation to cancer.
Purinergic Signal. 2025 May 8. doi: 10.1007/s11302-025-10089-4.
4
Leveraging adenosine triphosphate for cancer theranostics.
Theranostics. 2025 Mar 24;15(10):4708-4733. doi: 10.7150/thno.106291. eCollection 2025.
5
P2X7 receptor in macrophage polarization and its implications in neuroblastoma tumor behavior.
Purinergic Signal. 2025 Feb;21(1):51-68. doi: 10.1007/s11302-024-10051-w. Epub 2024 Oct 19.
6
P2 purinergic receptor expression and function in tumor-related immune cells.
Purinergic Signal. 2024 Oct 10. doi: 10.1007/s11302-024-10054-7.
7
Roles in Innate Immunity.
Adv Neurobiol. 2024;37:263-286. doi: 10.1007/978-3-031-55529-9_15.
8
Adenosine A receptor as a potential regulator of survival mechanisms: new insights into leprosy neural damage.
Front Pharmacol. 2024 Jun 28;15:1399363. doi: 10.3389/fphar.2024.1399363. eCollection 2024.
9
Ectonucleotidase inhibitors: targeting signaling pathways for therapeutic advancement-an in-depth review.
Purinergic Signal. 2025 Apr;21(2):221-265. doi: 10.1007/s11302-024-10031-0. Epub 2024 Jul 3.
10
"Find Me" and "Eat Me" signals: tools to drive phagocytic processes for modulating antitumor immunity.
Cancer Commun (Lond). 2024 Jul;44(7):791-832. doi: 10.1002/cac2.12579. Epub 2024 Jun 23.

本文引用的文献

1
Purines, purinergic receptors, and cancer.
Cancer Res. 2012 Nov 1;72(21):5441-7. doi: 10.1158/0008-5472.CAN-12-1600. Epub 2012 Oct 22.
2
P2 receptors and immunity.
Microbes Infect. 2012 Nov;14(14):1254-62. doi: 10.1016/j.micinf.2012.07.006. Epub 2012 Aug 13.
3
Diquafosol ophthalmic solution for dry eye treatment.
Adv Ther. 2012 Jul;29(7):579-89. doi: 10.1007/s12325-012-0033-9. Epub 2012 Jul 27.
4
The role of P2Y(14) and other P2Y receptors in degranulation of human LAD2 mast cells.
Purinergic Signal. 2013 Mar;9(1):31-40. doi: 10.1007/s11302-012-9325-4. Epub 2012 Jul 24.
5
Protection from asthma in a high-risk birth cohort by attenuated P2X(7) function.
J Allergy Clin Immunol. 2012 Aug;130(2):496-502. doi: 10.1016/j.jaci.2012.05.040. Epub 2012 Jun 27.
6
Information processing during phagocytosis.
Nat Rev Immunol. 2012 Jun 15;12(7):492-502. doi: 10.1038/nri3244.
7
Immunoregulation through extracellular nucleotides.
Blood. 2012 Jul 19;120(3):511-8. doi: 10.1182/blood-2012-01-406496. Epub 2012 Jun 1.
9
T cell homing to epithelial barriers in allergic disease.
Nat Med. 2012 May 4;18(5):705-15. doi: 10.1038/nm.2760.
10
P2X7 receptor-stimulation causes fever via PGE2 and IL-1β release.
FASEB J. 2012 Jul;26(7):2951-62. doi: 10.1096/fj.12-205765. Epub 2012 Apr 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验